LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ: SPRY) for violations of §§10(b) and 20(a) of the...
Cergy, September 22, 2026 – SPIE (the “ Company ”), the independent European leader in multi-technical services in the areas of energy and communications, today announces:
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 22, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ:CAPR) securities. If you suffered a loss on your Capricor Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Capricor Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 22, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired HDFC Bank Limited (NYSE:HDB) securities. If you suffered a loss on your HDFC Bank Limited investment and would like to explore a potential recovery under the federal securities laws, Learn about HDFC Bank Limited Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alarum Technologies Ltd. ("Alarum" or "the Company") (NASDAQ: ALAR) for violations of §§10(b) and 20(a) of...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 22, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Datavault AI Inc. (NASDAQ:DVLT) securities. If you suffered a loss on your Datavault AI Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Datavault AI Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 22, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rackspace Technology, Inc. (NASDAQ:RXT) securities. If you suffered a loss on your Rackspace Technology, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Rackspace Technology, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) LUND, SE / ACCESS Newswire / September 22, 2026 / SynAct Pharma AB (publ) ("SynAct") (STO:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced its attendance and presentations at multiple upcoming conferences in September and October 2026. BioStock Investing in Life Science 2026, September 22, Stockholm, Sweden Format: Company presentationPresenting: Jeppe Øvlesen, Chief Executive OfficerTime: Tuesday, September 22, 11:55am CESTLocation: Main session LSX Congress USA 2026, September 22-24, Boston, USA Format: Panel discussionPanel: From Seed to Scale: CEO Perspectives on Building Resilient Biotech Companies in Uncertain MarketsPanel Member: Mads Bjerregaard, Chief Bus
COMMUNIQUÉ DE PRESSE
PRESS RELEASE
Las pruebas de la Fase 1 identificaron firmas térmicas, de gases nobles y de materiales clave en el reactor de fusión por confinamiento en red (LCF); actualmente, Hylenr avanza hacia los estudios de la Fase 2, centrados en la reproducibilidad, la medición cuantitativa y la...